Neuropathic Pain Therapeutics Market, Global Outlook and Forecast 2022-2028

January 2022 | 63 pages | ID: N6BB3D3E82BAEN
Market Monitor Global

Abstracts

Neuropathic pain therapeutics refers to a way to relieve and treat neuropathic pain through various drugs or treatments. Neuropathic pain is a chronic condition wherein pathological pain continues even after the cause of the pain is eliminated.

This report contains market size and forecasts of Neuropathic Pain Therapeutics in Global, including the following market information:

Global Neuropathic Pain Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Neuropathic Pain Therapeutics market was valued at 8773.9 million in 2021 and is projected to reach US$ 10860 million by 2028, at a CAGR of 3.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anticonvulsants Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neuropathic Pain Therapeutics include Pfizer, Novartis AG, AstraZeneca, GlaxoSmithKline, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Johnson & Johnson, Abbott and Endo Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuropathic Pain Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neuropathic Pain Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Neuropathic Pain Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Anticonvulsants
• Antidepressants
• NSAIDs
• Opioids
• Steroids
• Others

Global Neuropathic Pain Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Neuropathic Pain Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Diabetic Neuropathy
• Chemotherapy-Induced Neuropathy Pain
• Postherpetic Neuralgia
• Spinal Cord Injury
• Others

Global Neuropathic Pain Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Neuropathic Pain Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neuropathic Pain Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Neuropathic Pain Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Novartis AG
• AstraZeneca
• GlaxoSmithKline
• Eli Lilly and Company
• Mallinckrodt Pharmaceuticals
• Johnson & Johnson
• Abbott
• Endo Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Limited
• Merck & Co

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neuropathic Pain Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neuropathic Pain Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEUROPATHIC PAIN THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Neuropathic Pain Therapeutics Market Size: 2021 VS 2028
2.2 Global Neuropathic Pain Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Neuropathic Pain Therapeutics Players in Global Market
3.2 Top Global Neuropathic Pain Therapeutics Companies Ranked by Revenue
3.3 Global Neuropathic Pain Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Neuropathic Pain Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neuropathic Pain Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuropathic Pain Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Neuropathic Pain Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Neuropathic Pain Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Neuropathic Pain Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Anticonvulsants
  4.1.3 Antidepressants
  4.1.4 NSAIDs
  4.1.5 Opioids
  4.1.6 Steroids
  4.1.7 Others
4.2 By Type - Global Neuropathic Pain Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Neuropathic Pain Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Neuropathic Pain Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neuropathic Pain Therapeutics Market Size, 2021 & 2028
  5.1.2 Diabetic Neuropathy
  5.1.3 Chemotherapy-Induced Neuropathy Pain
  5.1.4 Postherpetic Neuralgia
  5.1.5 Spinal Cord Injury
  5.1.6 Others
5.2 By Application - Global Neuropathic Pain Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Neuropathic Pain Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Neuropathic Pain Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Neuropathic Pain Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Neuropathic Pain Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Neuropathic Pain Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Neuropathic Pain Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Neuropathic Pain Therapeutics Revenue, 2017-2028
  6.3.2 US Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.3.3 Canada Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Neuropathic Pain Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Neuropathic Pain Therapeutics Revenue, 2017-2028
  6.4.2 Germany Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.4.3 France Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.4.5 Italy Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.4.6 Russia Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Neuropathic Pain Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Neuropathic Pain Therapeutics Revenue, 2017-2028
  6.5.2 China Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.5.3 Japan Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.5.6 India Neuropathic Pain Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Neuropathic Pain Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Neuropathic Pain Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Neuropathic Pain Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.7.3 Israel Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Neuropathic Pain Therapeutics Market Size, 2017-2028
  6.7.5 UAE Neuropathic Pain Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Neuropathic Pain Therapeutics Major Product Offerings
  7.1.4 Pfizer Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Novartis AG
  7.2.1 Novartis AG Corporate Summary
  7.2.2 Novartis AG Business Overview
  7.2.3 Novartis AG Neuropathic Pain Therapeutics Major Product Offerings
  7.2.4 Novartis AG Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Novartis AG Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Neuropathic Pain Therapeutics Major Product Offerings
  7.3.4 AstraZeneca Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Major Product Offerings
  7.4.4 GlaxoSmithKline Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline Key News
7.5 Eli Lilly and Company
  7.5.1 Eli Lilly and Company Corporate Summary
  7.5.2 Eli Lilly and Company Business Overview
  7.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Major Product Offerings
  7.5.4 Eli Lilly and Company Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly and Company Key News
7.6 Mallinckrodt Pharmaceuticals
  7.6.1 Mallinckrodt Pharmaceuticals Corporate Summary
  7.6.2 Mallinckrodt Pharmaceuticals Business Overview
  7.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Major Product Offerings
  7.6.4 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Mallinckrodt Pharmaceuticals Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Major Product Offerings
  7.7.4 Johnson & Johnson Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson Key News
7.8 Abbott
  7.8.1 Abbott Corporate Summary
  7.8.2 Abbott Business Overview
  7.8.3 Abbott Neuropathic Pain Therapeutics Major Product Offerings
  7.8.4 Abbott Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Abbott Key News
7.9 Endo Pharmaceuticals, Inc.
  7.9.1 Endo Pharmaceuticals, Inc. Corporate Summary
  7.9.2 Endo Pharmaceuticals, Inc. Business Overview
  7.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Major Product Offerings
  7.9.4 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Endo Pharmaceuticals, Inc. Key News
7.10 Teva Pharmaceutical Industries Limited
  7.10.1 Teva Pharmaceutical Industries Limited Corporate Summary
  7.10.2 Teva Pharmaceutical Industries Limited Business Overview
  7.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Major Product Offerings
  7.10.4 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Teva Pharmaceutical Industries Limited Key News
7.11 Merck & Co
  7.11.1 Merck & Co Corporate Summary
  7.11.2 Merck & Co Business Overview
  7.11.3 Merck & Co Neuropathic Pain Therapeutics Major Product Offerings
  7.11.4 Merck & Co Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Merck & Co Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Neuropathic Pain Therapeutics Market Opportunities & Trends in Global Market
Table 2. Neuropathic Pain Therapeutics Market Drivers in Global Market
Table 3. Neuropathic Pain Therapeutics Market Restraints in Global Market
Table 4. Key Players of Neuropathic Pain Therapeutics in Global Market
Table 5. Top Neuropathic Pain Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Neuropathic Pain Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Neuropathic Pain Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Neuropathic Pain Therapeutics Product Type
Table 9. List of Global Tier 1 Neuropathic Pain Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuropathic Pain Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Neuropathic Pain Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Neuropathic Pain Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Neuropathic Pain Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Neuropathic Pain Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Neuropathic Pain Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Neuropathic Pain Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Neuropathic Pain Therapeutics Product Offerings
Table 32. Pfizer Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Novartis AG Corporate Summary
Table 34. Novartis AG Neuropathic Pain Therapeutics Product Offerings
Table 35. Novartis AG Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Neuropathic Pain Therapeutics Product Offerings
Table 38. AstraZeneca Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Neuropathic Pain Therapeutics Product Offerings
Table 41. GlaxoSmithKline Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly and Company Corporate Summary
Table 43. Eli Lilly and Company Neuropathic Pain Therapeutics Product Offerings
Table 44. Eli Lilly and Company Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Mallinckrodt Pharmaceuticals Corporate Summary
Table 46. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product Offerings
Table 47. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Neuropathic Pain Therapeutics Product Offerings
Table 50. Johnson & Johnson Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Abbott Corporate Summary
Table 52. Abbott Neuropathic Pain Therapeutics Product Offerings
Table 53. Abbott Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Endo Pharmaceuticals, Inc. Corporate Summary
Table 55. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product Offerings
Table 56. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Teva Pharmaceutical Industries Limited Corporate Summary
Table 58. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product Offerings
Table 59. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Merck & Co Corporate Summary
Table 61. Merck & Co Neuropathic Pain Therapeutics Product Offerings
Table 62. Merck & Co Neuropathic Pain Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Neuropathic Pain Therapeutics Segment by Type in 2021
Figure 2. Neuropathic Pain Therapeutics Segment by Application in 2021
Figure 3. Global Neuropathic Pain Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neuropathic Pain Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neuropathic Pain Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuropathic Pain Therapeutics Revenue in 2021
Figure 8. By Type - Global Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis AG Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly and Company Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Abbott Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck & Co Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)